Article
Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer.
Current pharmaceutical design - 1 Jan 2014
Bruegl Amanda S, Djordjevic Bojana, Urbauer Diana L, Westin Shannon N, Soliman Pamela T, Lu Karen H, Luthra Rajyalakshmi, Broaddus Russell R
Abstract excerpt
Clinical screening criteria, such as young age of endometrial cancer diagnosis and family history of signature cancers, have traditionally been used to identify women with Lynch Syndrome, which is caused by mutation of a DNA mismatch repair gene. Immunohistochemistry and microsatellite instability analysis have evolved as important screening tools to evaluate endometrial cancer patients for Lynch Syndrome. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
